Update: 11.07.2023
Last week: 26 week 2023 (26.06.2023 - 02.07.2023)
Last full month: June 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 62 996 | -6.3% | 2.9% | 0.1 | 15 156 990 | -5.5% | 3.2% | 0.1 | -9.9% |
| MoM | 287 038 | -8.7% | 2.8% | 0.1 | 69 325 574 | -11.4% | 3.1% | 0 | -13.4% |
| YTD | 2 308 100 | -62.1% | 2.7% | -3.2 | 597 631 916 | -50.4% | 3.2% | -2.4 | -17.3% |
| MAT | 6 060 228 | -59.6% | 3.2% | -3.5 | 1 413 005 102 | -49.1% | 3.5% | -2.7 | -15.7% |
| DEXALGIN | |||||||||
| WoW | 19 084 | -4.4% | 0.4% | 0 | 9 699 784 | -2.7% | 1.2% | 0 | -2.7% |
| MoM | 81 267 | 15.4% | 0.4% | 0.1 | 40 761 006 | 14.2% | 1.2% | 0.1 | 0.3% |
| YTD | 448 705 | -58.0% | 0.4% | -0.4 | 233 769 882 | -47.1% | 1.1% | -1 | -8.4% |
| MAT | 966 769 | -54.0% | 0.4% | -0.4 | 478 848 199 | -42.8% | 1.2% | -0.9 | -9.1% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 58 410 | -6.0% | 40.1% | -0.7 | 33 712 164 | -6.9% | 46.3% | -1.7 | -4.3% |
| MoM | 247 607 | 5.4% | 39.8% | -0.1 | 144 530 399 | 3.9% | 46.7% | -0.5 | 5.6% |
| YTD | 1 438 252 | -47.4% | 39.9% | -19 | 881 891 051 | -36.1% | 48.4% | -15.9 | -22.4% |
| MAT | 2 986 969 | -45.8% | 42.7% | -19.2 | 1 711 318 134 | -36.4% | 50.0% | -17.2 | -21.5% |
| ESPUMISAN BABY | |||||||||
| WoW | 20 833 | -16.3% | 31.6% | -3.6 | 15 060 566 | -19.4% | 45.6% | -5 | -6.8% |
| MoM | 92 893 | 5.3% | 32.7% | 1.5 | 68 479 934 | 5.5% | 47.4% | 1.1 | 0.5% |
| YTD | 542 127 | -33.4% | 30.6% | -9.2 | 410 585 257 | -17.9% | 46.5% | -6.4 | -13.4% |
| MAT | 1 154 723 | -29.5% | 32.5% | -7.9 | 816 064 887 | -17.4% | 47.1% | -6.9 | -12.2% |
| FASTUM | |||||||||
| WoW | 15 426 | -2.7% | 0.9% | 0 | 9 201 942 | -1.1% | 2.2% | 0.1 | -8.1% |
| MoM | 65 519 | 2.6% | 0.8% | 0 | 39 279 575 | 1.9% | 2.1% | 0 | -0.8% |
| YTD | 385 331 | -38.8% | 0.9% | -0.5 | 233 731 573 | -26.7% | 2.2% | -0.5 | -6.3% |
| MAT | 795 839 | -38.8% | 0.9% | -0.5 | 461 258 518 | -26.9% | 2.2% | -0.7 | -5.2% |
| IODOMARIN | |||||||||
| WoW | 67 554 | -1.5% | 23.9% | 0.8 | 12 137 409 | -1.1% | 10.1% | 0.6 | -4.6% |
| MoM | 281 695 | 1.3% | 22.9% | 0.1 | 50 556 856 | 0.3% | 9.4% | 0.1 | 0.8% |
| YTD | 1 761 269 | 13.5% | 22.8% | 4.3 | 323 127 069 | 2.9% | 9.2% | 0.8 | -7.9% |
| MAT | 3 502 244 | 5.3% | 22.8% | 2.3 | 649 211 410 | 0.6% | 9.5% | 0.2 | -5.2% |
| LIOTON | |||||||||
| WoW | 21 821 | -10.4% | 2.0% | -0.1 | 27 084 058 | -9.8% | 4.6% | -0.2 | -6.3% |
| MoM | 99 565 | 13.5% | 2.1% | 0.2 | 122 413 385 | 9.7% | 4.7% | 0.2 | 2.4% |
| YTD | 479 894 | -38.1% | 1.8% | -0.7 | 601 960 601 | -23.2% | 4.4% | -0.5 | -13.6% |
| MAT | 955 772 | -40.8% | 1.8% | -0.9 | 1 125 380 205 | -25.3% | 4.3% | -1.1 | -13.3% |
| MEZYM | |||||||||
| WoW | 206 442 | -3.2% | 17.6% | 0 | 33 658 696 | -2.4% | 12.6% | 0.3 | -3.2% |
| MoM | 882 207 | 1.1% | 17.8% | 0.3 | 142 318 636 | 3.3% | 12.4% | 0.2 | -0.5% |
| YTD | 5 516 088 | -51.3% | 18.4% | -11.2 | 871 064 795 | -49.7% | 12.6% | -8.6 | -21.8% |
| MAT | 11 533 876 | -50.4% | 19.2% | -11.6 | 1 781 700 911 | -47.4% | 13.4% | -9.1 | -20.4% |
| MIG 400 | |||||||||
| WoW | 106 911 | -6.8% | 2.3% | -0.1 | 14 786 125 | -7.2% | 1.8% | -0.1 | -2.7% |
| MoM | 499 064 | -5.4% | 2.5% | -0.2 | 69 190 969 | -1.7% | 2.0% | -0.1 | 0.3% |
| YTD | 3 053 269 | -35.6% | 2.4% | -1 | 389 119 457 | -30.0% | 1.9% | -0.7 | -8.4% |
| MAT | 6 705 679 | -35.8% | 2.6% | -1.1 | 827 102 386 | -30.6% | 2.0% | -0.9 | -9.1% |
| PROSTAMOL | |||||||||
| WoW | 18 932 | -7.3% | 12.6% | -0.6 | 28 156 513 | -8.3% | 13.6% | -0.8 | -3.0% |
| MoM | 83 911 | -0.4% | 13.1% | -0.1 | 125 068 636 | 1.5% | 14.2% | 0.1 | 0.1% |
| YTD | 530 001 | -44.8% | 13.0% | -7.9 | 788 732 347 | -41.5% | 14.3% | -7.9 | -11.4% |
| MAT | 1 117 177 | -45.7% | 14.0% | -8.9 | 1 604 897 556 | -41.6% | 15.0% | -9.2 | -11.2% |
| RESPERO MYRTOL | |||||||||
| WoW | 13 116 | -11.7% | 7.3% | 0 | 7 073 262 | -9.3% | 7.6% | 0.3 | -11.8% |
| MoM | 66 022 | -11.4% | 7.4% | 0.8 | 34 761 396 | -11.5% | 7.4% | 0.8 | -20.7% |
| YTD | 528 808 | -25.9% | 7.0% | -1.8 | 291 569 143 | -12.2% | 7.6% | -1 | -6.3% |
| MAT | 1 116 892 | -9.4% | 7.4% | -0.4 | 582 942 228 | 2.7% | 7.9% | 0.2 | -4.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 2 308 100 | -62.1% | 2.7% | -3.2 | 597 631 916 | -50.4% | 3.2% | -2.4 | -17.3% |
| DEXALGIN | 448 705 | -58.0% | 0.4% | -0.4 | 233 769 882 | -47.1% | 1.1% | -1 | -8.4% |
| ESPUMISAN (ADULTS) | 1 438 252 | -47.4% | 39.9% | -19 | 881 891 051 | -36.1% | 48.4% | -15.9 | -22.4% |
| ESPUMISAN BABY | 542 127 | -33.4% | 30.6% | -9.2 | 410 585 257 | -17.9% | 46.5% | -6.4 | -13.4% |
| FASTUM | 385 331 | -38.8% | 0.9% | -0.5 | 233 731 573 | -26.7% | 2.2% | -0.5 | -6.3% |
| IODOMARIN | 1 761 269 | 13.5% | 22.8% | 4.3 | 323 127 069 | 2.9% | 9.2% | 0.8 | -7.9% |
| LIOTON | 479 894 | -38.1% | 1.8% | -0.7 | 601 960 601 | -23.2% | 4.4% | -0.5 | -13.6% |
| MEZYM | 5 516 088 | -51.3% | 18.4% | -11.2 | 871 064 795 | -49.7% | 12.6% | -8.6 | -21.8% |
| MIG | 3 053 269 | -35.6% | 2.4% | -1 | 389 119 457 | -30.0% | 1.9% | -0.7 | -8.4% |
| PROSTAMOL | 530 001 | -44.8% | 13.0% | -7.9 | 788 732 347 | -41.5% | 14.3% | -7.9 | -11.4% |
| RESPERO MYRTOL | 528 808 | -25.9% | 7.0% | -1.8 | 291 569 143 | -12.2% | 7.6% | -1 | -6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 060 228 | -59.6% | 3.2% | -3.5 | 1 413 005 102 | -49.1% | 3.5% | -2.7 | -15.7% |
| DEXALGIN | 966 769 | -54.0% | 0.4% | -0.4 | 478 848 199 | -42.8% | 1.2% | -0.9 | -9.1% |
| ESPUMISAN (ADULTS) | 2 986 969 | -45.8% | 42.7% | -19.2 | 1 711 318 134 | -36.4% | 50.0% | -17.2 | -21.5% |
| ESPUMISAN BABY | 1 154 723 | -29.5% | 32.5% | -7.9 | 816 064 887 | -17.4% | 47.1% | -6.9 | -12.2% |
| FASTUM | 795 839 | -38.8% | 0.9% | -0.5 | 461 258 518 | -26.9% | 2.2% | -0.7 | -5.2% |
| IODOMARIN | 3 502 244 | 5.3% | 22.8% | 2.3 | 649 211 410 | 0.6% | 9.5% | 0.2 | -5.2% |
| LIOTON | 955 772 | -40.8% | 1.8% | -0.9 | 1 125 380 205 | -25.3% | 4.3% | -1.1 | -13.3% |
| MEZYM | 11 533 876 | -50.4% | 19.2% | -11.6 | 1 781 700 911 | -47.4% | 13.4% | -9.1 | -20.4% |
| MIG | 6 705 679 | -35.8% | 2.6% | -1.1 | 827 102 386 | -30.6% | 2.0% | -0.9 | -9.1% |
| PROSTAMOL | 1 117 177 | -45.7% | 14.0% | -8.9 | 1 604 897 556 | -41.6% | 15.0% | -9.2 | -11.2% |
| RESPERO MYRTOL | 1 116 892 | -9.4% | 7.4% | -0.4 | 582 942 228 | 2.7% | 7.9% | 0.2 | -4.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 62 996 | -6.3% | 2.9% | 0.1 | 15 156 990 | -5.5% | 3.2% | 0.1 | -9.9% |
| DEXALGIN | 19 084 | -4.4% | 0.4% | 0 | 9 699 784 | -2.7% | 1.2% | 0 | -2.7% |
| ESPUMISAN (ADULTS) | 58 410 | -6.0% | 40.1% | -0.7 | 33 712 164 | -6.9% | 46.3% | -1.7 | -4.3% |
| ESPUMISAN BABY | 20 833 | -16.3% | 31.6% | -3.6 | 15 060 566 | -19.4% | 45.6% | -5 | -6.8% |
| FASTUM | 15 426 | -2.7% | 0.9% | 0 | 9 201 942 | -1.1% | 2.2% | 0.1 | -8.1% |
| IODOMARIN | 67 554 | -1.5% | 23.9% | 0.8 | 12 137 409 | -1.1% | 10.1% | 0.6 | -4.6% |
| LIOTON | 21 821 | -10.4% | 2.0% | -0.1 | 27 084 058 | -9.8% | 4.6% | -0.2 | -6.3% |
| MEZYM | 206 442 | -3.2% | 17.6% | 0 | 33 658 696 | -2.4% | 12.6% | 0.3 | -3.2% |
| MIG | 106 911 | -6.8% | 2.3% | -0.1 | 14 786 125 | -7.2% | 1.8% | -0.1 | -2.7% |
| PROSTAMOL | 18 932 | -7.3% | 12.6% | -0.6 | 28 156 513 | -8.3% | 13.6% | -0.8 | -3.0% |
| RESPERO MYRTOL | 13 116 | -11.7% | 7.3% | 0 | 7 073 262 | -9.3% | 7.6% | 0.3 | -11.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 287 038 | -8.7% | 2.8% | 0.1 | 69 325 574 | -11.4% | 3.1% | 0 | -13.4% |
| DEXALGIN | 81 267 | 15.4% | 0.4% | 0.1 | 40 761 006 | 14.2% | 1.2% | 0.1 | 0.3% |
| ESPUMISAN (ADULTS) | 247 607 | 5.4% | 39.8% | -0.1 | 144 530 399 | 3.9% | 46.7% | -0.5 | 5.6% |
| ESPUMISAN BABY | 92 893 | 5.3% | 32.7% | 1.5 | 68 479 934 | 5.5% | 47.4% | 1.1 | 0.5% |
| FASTUM | 65 519 | 2.6% | 0.8% | 0 | 39 279 575 | 1.9% | 2.1% | 0 | -0.8% |
| IODOMARIN | 281 695 | 1.3% | 22.9% | 0.1 | 50 556 856 | 0.3% | 9.4% | 0.1 | 0.8% |
| LIOTON | 99 565 | 13.5% | 2.1% | 0.2 | 122 413 385 | 9.7% | 4.7% | 0.2 | 2.4% |
| MEZYM | 882 207 | 1.1% | 17.8% | 0.3 | 142 318 636 | 3.3% | 12.4% | 0.2 | -0.5% |
| MIG | 499 064 | -5.4% | 2.5% | -0.2 | 69 190 969 | -1.7% | 2.0% | -0.1 | 0.3% |
| PROSTAMOL | 83 911 | -0.4% | 13.1% | -0.1 | 125 068 636 | 1.5% | 14.2% | 0.1 | 0.1% |
| RESPERO MYRTOL | 66 022 | -11.4% | 7.4% | 0.8 | 34 761 396 | -11.5% | 7.4% | 0.8 | -20.7% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"
## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"
## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"
## [1] "ESPUMISAN (ADULTS)"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"
## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"
## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"
## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"
## [1] "ESPUMISAN BABY"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"
## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"
## [1] "FASTUM"
## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"
## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"
## [1] "LIOTON"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"
## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"
## [1] "MEZYM"
## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"
## [1] "MEZYM FORTE COATED TABLETS #20"
## [1] "MEZYM FORTE COATED TABLETS #80"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"
## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"
## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"
## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"
## [1] "DEXALGIN"
## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"
## [1] "MIG"
## [1] "MIG 400 COATED TABLETS 400 MG #10"
## [1] "MIG 400 COATED TABLETS 400 MG #20"
## [1] "PROSTAMOL"
## [1] "PROSTAMOL UNO CAPS 320 MG #30"
## [1] "PROSTAMOL UNO CAPS 320 MG #60"
## [1] "PROSTAMOL UNO CAPS 320 MG #90"
## [1] "IODOMARIN"
## [1] "IODOMARIN 100 TABS 100 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #100"
## [1] "IODOMARIN 200 TABS 200 MCG #50"
## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"
## [1] "RESPERO MYRTOL"
## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"
## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs